Lv1
48 积分 2023-06-08 加入
An Industry Perspective on Key Considerations for the ICH S13 Guidance: Nonclinical Safety Evaluations of Oligonucleotide-Based Therapeutics
3天前
已完结
Psoriasis
30天前
已完结
Guideline for the diagnosis and treatment of psoriasis in China （2018 complete edition）
30天前
已关闭
单克隆抗体药物风险因素分析及 非临床研究与评价的一般考虑
3个月前
已完结
Personalized care for patients with EGFR‐mutant nonsmall cell lung cancer: Navigating early to advanced disease management
5个月前
已完结
The rise of China’s pharmaceutical industry from 2015–2024: a decade of innovation
7个月前
已完结
A bispecific antibody–drug conjugate targeting EGFR and HER3 in metastatic esophageal squamous cell carcinoma: a phase 1b trial
1年前
已完结
A mechanistic quantitative systems pharmacology model platform for translational efficacy evaluation and checkpoint combination design of bispecific immuno-modulatory antibodies
1年前
已完结
Engineering CD3/CD137 Dual Specificity into a DLL3-Targeted T-Cell Engager Enhances T-Cell Infiltration and Efficacy against Small-Cell Lung Cancer
1年前
已完结
皖公网安备34019202002308
